...
首页> 外文期刊>Journal of cardiovascular pharmacology and therapeutics >Advancements in induced pluripotent stem cell technology for cardiac regenerative medicine
【24h】

Advancements in induced pluripotent stem cell technology for cardiac regenerative medicine

机译:诱导多能干细胞技术在心脏再生医学中的研究进展

获取原文
获取原文并翻译 | 示例
           

摘要

Cardiovascular diseases remain the leading causes of morbidity and mortality in the developed world. Cellular-based cardiac regenerative therapy serves as a potential approach to treating cardiovascular diseases. Although various cellular types have been tested, induced pluripotent stem cells (iPSCs) are regarded as a promising cell source for therapy. In this review, we will highlight some of the advances in generating iPSCs and differentiation to cardiac cells. We will also discuss the progress in modeling cardiovascular diseases using iPSCs-derived cardiac cells. As we continue to make progress in iPSC and cardiac differentiation technology, we will come closer to the application of cardiac regenerative medicine.
机译:在发达国家,心血管疾病仍然是发病率和死亡率的主要原因。基于细胞的心脏再生疗法是治疗心血管疾病的一种潜在方法。尽管已经测试了多种细胞类型,但诱导多能干细胞(iPSC)被认为是有希望的治疗细胞来源。在这篇综述中,我们将重点介绍在产生iPSC和分化为心肌细胞方面的一些进展。我们还将讨论使用iPSCs衍生的心肌细胞对心血管疾病进行建模的进展。随着iPSC和心脏分化技术的不断发展,我们将更接近于心脏再生医学的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号